Magnus BRISANDER,Mustafa DEMIRBÜKER,Gérald JESSON,Martin MALMSTEN,Helene DÉRAND
申请号：
US16403969
公开号：
US20190275018A1
申请日:
2019.05.06
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.
